Publicaciones Científicas

  • 31/03/2023

    Frontiers in oncology

    Editorial: Artificial intelligence: A step forward in biomarker discovery and integration towards improved cancer diagnosis and treatment

    Mónica Hebe Vazquez-Levin, Jaume Reventos, George Zaki

  • 28/03/2023

    Cell reports

    Concomitant inhibition of PPARγ and mTORC1 induces the differentiation of human monocytes into highly immunogenic dendritic cells

    Fernando Erra Diaz, Ignacio Mazzitelli, Lucía Bleichmar, Claudia Melucci, Asa Thibodeau, Tomás Dalotto Moreno, Radu Marches, Gabriel A Rabinovich, Duygu Ucar, Jorge Geffner

  • 26/03/2023

    Cancers

    Emerging Targeted Therapies for HER2-Positive Breast Cancer

    María Florencia Mercogliano, Sofía Bruni, Florencia Luciana Mauro, Roxana Schillaci

  • 17/03/2023

    Cell reports. Medicine

    mRNAs encoding IL-12 and a decoy-resistant variant of IL-18 synergize to engineer T cells for efficacious intratumoral adoptive immunotherapy

    Irene Olivera, Elixabet Bolaños, Jose Gonzalez-Gomariz, Sandra Hervas-Stubbs, Karina V Mariño, Carlos Luri-Rey, Iñaki Etxeberria, Assunta Cirella, Josune Egea, Javier Glez-Vaz, Saray Garasa, Maite Alvarez, Iñaki Eguren-Santamaria, Sonia Guedan, Miguel F Sanmamed, Pedro Berraondo, Gabriel A Rabinovich, Alvaro Teijeira, Ignacio Melero

  • 05/03/2023

    International journal of pharmaceutics

    Silica-collagen nanoformulations with extended human growth hormone release

    Luis A Villarruel, Belén Brie, Sofía Municoy, Damasia Becú-Villalobos, Martín F Desimone, Paolo N Catalano 

  • Journal for Immunotherapy of Cancer

    01/03/2023

    Journal for immunotherapy of cancer

    Blocking soluble TNFα sensitizes HER2-positive breast cancer to trastuzumab through MUC4 downregulation and subverts immunosuppression

    Sofia Bruni, Florencia L Mauro, Cecilia J Proietti, Rosalia I Cordo-Russo, Martin A Rivas, Gloria Inurrigarro, Agustina Dupont, Dario Rocha, Elmer A Fernández, Ernesto Gil Deza, Daniel Lopez Della Vecchia, Sabrina Barchuk, Silvina Figurelli, David Lasso, Adrián D Friedrich, María C Santilli, María V Regge, Gabriel Lebersztein, Claudio Levit, Fabiana Anfuso, Teresa Castiglione, Patricia V Elizalde, Maria F Mercogliano, Roxana Schillaci

  • 01/03/2023

    Clinical Cancer Research

    Beneficial effects of mifepristone treatment in breast cancer patients selected by the progesterone receptor isoform ratio: Results from the MIPRA trial

    Andrés Elía, Leo Saldain, Silvia I Vanzulli, Luisa A Helguero, Caroline A Lamb, Victoria Fabris, Gabriela Pataccini, Paula Martínez-Vazquez, Javier Burruchaga, Ines Caillet-Bois, Eunice Spengler, Gabriela Acosta Haab, Marcos Liguori, Alejandra Castets, Silvia Lovisi, María F Abascal, Virginia Novaro, Jana Sánchez, Javier Muñoz, Jose M Belizán, Martín C Abba, Hugo Gass, Paola Rojas, Claudia Lanari

  • 23/02/2023

    Journal of cellular biochemistry

    Mitochondrial-nuclear communication by FKBP51 shuttling

    Nadia Zgajnar, Mariana Lagadari, Luciana I Gallo, Graciela Piwien-Pilipuk, Mario D Galigniana

  • 20/02/2023

    Frontiers in oncology

    Spontaneous Osteoclastogenesis, a risk factor for bone metastasis in advanced luminal A-type breast cancer patients

    Valeria Fernández Vallone, Francisco Raúl Borzone, Leandro Marcelo Martinez, María Belén Giorello, Hosoon Choi, Federico Dimase, Leonardo Feldman, Raúl Horacio Bordenave, Ana Marisa Chudzinski-Tavassi, Emilio Batagelj, Norma Alejandra Chasseing

  • 15/02/2023

    Scientific reports

    Targeting mTOR to overcome resistance to hormone and CDK4/6 inhibitors in ER-positive breast cancer models

    María Jimena Rodriguez, María Cecilia Perrone, Marina Riggio, Marta Palafox, Valeria Salinas, Andrés Elia, Natali Daiana Salgueiro, Andrea Eugenia Werbach, María Paula Marks, Marcelo A Kauffman, Luciano Vellón, Violeta Serra, Virginia Novaro